As the percentage of the world's population over the age of 65 continues to grow, anti-aging programs are gaining popularity, driven by advances in technology and increasing research into human longevity. The desire to improve the quality and length of life is driving technologies and treatments aimed at slowing the aging process and maintaining health.
The mainstay of anti-aging therapy is epigenetic reprogramming. It reverses or modifies epigenetic markers associated with aging, rejuvenating cells and tissues and potentially slowing or reversing the effects of aging hong kong phone number library and even age-related diseases. Below are examples of companies that are engaged in similar research and show great promise.
Grail – early cancer detection
California-based GRAIL specializes in oncology with early cancer detection technology. The medical device company has developed a methylation-based cancer detection platform known as Galleri. It combines next-generation sequencing and large-scale clinical trials with machine learning, software, and automation to detect and identify multiple types of cancer and monitor recurrence.
This year, GRAIL launched a three-year study to evaluate the clinical impact of the Galleri test for early detection of multiple cancers in the Medicare population by assessing the safety of the test and any reduction in diagnosed cases of stage IV cancer in a population of approximately 50,000 people who undergo the test each year, compared to a group that does not. The U.S. Food and Drug Administration (FDA) has granted GRAIL permission to use the investigational device for the trial.
Verve Therapeutics – protection against atherosclerosis
Verve Therapeutics, a clinical-stage company, is developin